| 000 | 00876 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250510211220.0 | ||
| 264 | 0 | _c19790629 | |
| 008 | 197906s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(78)93032-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaro, J F | |
| 245 | 0 | 0 |
_aPropranolol therapy for hyperparathyroidism? _h[electronic resource] |
| 260 |
_bLancet (London, England) _cApr 1978 |
||
| 300 |
_a827 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperparathyroidism _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropranolol _xtherapeutic use |
| 700 | 1 | _aBesarab, A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8068 _gp. 827 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(78)93032-5 _zAvailable from publisher's website |
| 999 |
_c83861 _d83861 |
||